Technical Analysis for ACAD - ACADIA Pharmaceuticals Inc.

Grade Last Price % Change Price Change
grade D 18.93 1.61% 0.30
ACAD closed up 1.61 percent on Friday, November 16, 2018, on 55 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical ACAD trend table...

Date Alert Name Type % Chg
Nov 16 Wide Bands Range Expansion 0.00%
Nov 16 Oversold Stochastic Weakness 0.00%
Nov 15 Bullish Engulfing Bullish 1.61%
Nov 15 Stochastic Buy Signal Bullish 1.61%
Nov 15 Wide Bands Range Expansion 1.61%
Nov 15 Oversold Stochastic Weakness 1.61%
Nov 14 Golden Cross Bullish 7.99%
Nov 14 Lower Bollinger Band Walk Weakness 7.99%
Nov 14 Wide Bands Range Expansion 7.99%
Nov 14 Lower Bollinger Band Touch Weakness 7.99%

Older signals for ACAD ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on small molecule drugs that address unmet medical needs in neurological and related central nervous system disorders. The company has a pipeline of product candidates led by pimavanserin, which is in Phase III development stage for the treatment of Parkinson's disease psychosis. It is also developing pimavanserin that has completed Phase II co-therapy trials for the treatment of schizophrenia; and is in Phase II clinical trials for the treatment of Alzheimer's disease psychosis. In addition, the company, through collaboration with Allergan, Inc., is developing alpha adrenergic agonists, which are in Phase II clinical trials for the treatment of chronic pain; and muscarinic agonist that is in Phase I clinical trials for the treatment of glaucoma. Further, it is developing two advanced preclinical programs directed at Parkinson's disease and other neurological disorders. The company was formerly known as Receptor Technologies, Inc. ACADIA Pharmaceuticals Inc. was founded in 1993 and is headquartered in San Diego, California.
Is ACAD a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 32.99
52 Week Low 12.77
Average Volume 3,154,421
200-Day Moving Average 19.3824
50-Day Moving Average 19.6984
20-Day Moving Average 20.309
10-Day Moving Average 19.341
Average True Range 1.5994
ADX 22.25
+DI 15.2505
-DI 22.408
Chandelier Exit (Long, 3 ATRs ) 18.7518
Chandelier Exit (Short, 3 ATRs ) 21.8182
Upper Bollinger Band 23.4544
Lower Bollinger Band 17.1636
Percent B (%b) 0.28
BandWidth 30.97543
MACD Line -0.5178
MACD Signal Line -0.1252
MACD Histogram -0.3926
Fundamentals Value
Market Cap 2.32 Billion
Num Shares 122 Million
EPS -2.53
Price-to-Earnings (P/E) Ratio -7.48
Price-to-Sales 67.33
Price-to-Book 10.21
PEG Ratio -0.41
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 20.61
Resistance 3 (R3) 20.53 19.88 20.33
Resistance 2 (R2) 19.88 19.46 19.93 20.24
Resistance 1 (R1) 19.41 19.19 19.65 19.49 20.14
Pivot Point 18.76 18.76 18.88 18.81 18.76
Support 1 (S1) 18.29 18.34 18.53 18.37 17.72
Support 2 (S2) 17.64 18.07 17.69 17.62
Support 3 (S3) 17.17 17.64 17.53
Support 4 (S4) 17.25